Doctors are at the forefront of efforts to protect and enhance health, applying their expertise to lead patients through medical challenges, lead their profession to new heights of effective care, and lead their fellow clinical team members to greater collaboration. Some physicians excel on all of these fronts, embodying true excellence in their medical specialty and representing the best of the best in terms of their skill, professionalism, and patient-centered focus.
These qualities are found in abundance at Regional Cancer Care Associates (RCCA), one of the nation’s largest networks of oncology specialists. Practicing at more than 20 care centers throughout New Jersey, Connecticut, Maryland, and the Washington, D.C. area, each year RCCA’s 80+ oncology specialists provide cutting-edge, highly individualized, and compassionate care to more than 225,000 new and established patients with solid tumors, blood-based malignancies, and benign hematologic conditions
The impact that RCCA’s doctors are having on cancer care in the Garden State is well-recognized by their colleagues. That recognition is reflected in the fact that 16 of RCCA’s physicians recently were named ‘2021 Top Doctors’ in New Jersey by healthcare research and information company Castle Connolly, America’s trusted source for identifying top doctors through an exhaustive and independent process of peer nomination, research, review, and screening.
The 16 RCCA physicians named to Castle Connolly’s prestigious list of 2021 Top Doctors in New Jersey are:
Of the more than 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The designation is bestowed only after a rigorous vetting process conducted by an experienced medical review board. Reviewers consider each doctors’ skills, professionalism, training/qualifications, experience, competence, outcomes, and achievements as well as his or her relational skills and empathy toward patients.
“RCCA is delighted that so many of our cancer specialists have been selected by their fellow physicians and Castle Connolly as ‘Top Doctors,’” said Terrill Jordan, president and chief executive officer of RCCA. “The RCCA oncologists honored this year epitomize the dedication to providing outstanding cancer care that drives all of our oncology specialists day in and day out, year after year, and we feel extremely proud and privileged to work with them.”
“To be recognized by your peers as a ‘Top Doctor’ is a great testament to a physician’s expertise and experience, and I congratulate my RCCA colleagues who have received this well-deserved honor,” noted Iuliana Shapira, MD, RCCA chief medical officer. “The only recognition that means more to a doctor is that provided by his or her patients, and I’m proud that all of our physicians routinely win high marks from our patients and their families, causing RCCA to consistently have a top ranking in nationwide patient-satisfaction surveys conducted by the Community Oncology Alliance.”
“At RCCA, we’re committed to providing the latest therapies, treatment strategies, and clinical trials within a convenient, community setting and in a compassionate manner,” Dr. Shapira said. “We’re proud that our cancer specialists take the time to get to know each patient as an individual, address any questions or concerns that the patient and family members may have, and incorporate the patient’s goals, preferences, and quality of life into our treatment plans. The selection of so many RCCA cancer specialists as ‘Top Doctors’ and the high patient-satisfaction marks that all of our physicians receive are reflections of that commitment and passion.”
With more than 80 oncology physicians practicing at 20+ RCCA care centers throughout New Jersey, Connecticut, Maryland, and the Washington, D.C. area, RCCA provides everything from immunotherapy, targeted treatment, cell-based therapy and other cutting-edge treatments and diagnostic modalities as well as access to clinical trials to roughly 22,000 new cancer patients and 225,000 established patients each year. RCCA care centers also provide infusion services for patients with non-oncology conditions — such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease, and others — who are being treated with intravenously-administered medications. To learn more about RCCA or to schedule an appointment, call 844-928-0089 or visit www.RCCA.com.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.
Cancer can affect anyone from any background. However, some racial and ethnic groups have higher rates of certain kinds of cancer. Regional Cancer Care Associates
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different conditions can be managed and
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
